CD70 Targeted CAR-T Cells Therapy(UTC Therapeutics)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameCD70 Targeted CAR-T Cells Therapy(UTC Therapeutics)
Drug Alias NameAutologous CD70 targeted chimeric antigen receptor modified T (CAR-T) cell therapy(UTC Therapeutics)CD70-targeting CAR-T cells therapy(UTC Therapeutics)Anti-CD70 CAR-T cells therapy(UTC Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacementsAnti-CD70
TargetsCD70 antigen
Therapy Area/IndicationsSolid tumoursUrologic NeoplasmsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesUTC Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUTC Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrologic NeoplasmsLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A